A Cambridge-based biotech is working with Mass General Brigham’s Gene and Cell Therapy Institute to launch what they say will be the nation's first hospital facility that manufactures patient-specific stem cells.
Nabiha Saklayen, co-founder and chief executive of Cellino, has worked for years to radically change the manufacturing process for patient-specific stem cells used in personalized cell and tissue therapies. She sees a future where her company's technology could enable the production of these cells autonomously and directly at hospitals or clinics. The partnership with MGB will make that vision a reality.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal
